NCT06754228View on ClinicalTrials.gov

Acute Immune Modulation by Probiotic Strain

NARecruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

November 13, 2024

Primary Completion Date

September 1, 2025

Study Completion Date

December 15, 2025

Conditions
Immune Surveillance
Interventions
DIETARY_SUPPLEMENT

Probiotic Agent

Bacillus coagulans JBI-YZ6.3 (BC4U)

DIETARY_SUPPLEMENT

Probiotic Agent

An escalating dose cross-over design: Participants are fed 0 mg, 100 mg, 200 mg, and 400 mg on different clinic visits.

Trial Locations (1)

97601

RECRUITING

NIS Labs, Klamath Falls

Sponsors

Collaborators (1)

Jeneil Biotech Inc.
All Listed Sponsors
collaborator

Jeneil Biotech Inc.

UNKNOWN

lead

Natural Immune Systems Inc

OTHER